Aims and Scope
Lung Cancer is a peer-reviewed medical journal published by Elsevier originally published on behalf of the International Association for the Study of Lung Cancer (until 2006). As of 2015, it is published on behalf of the International Lung Cancer Consortium, the European Thoracic Oncology Platform, and the British Thoracic Oncology Group. It includes original research and review articles of relevance to lung cancer. Less
Key Metrics
Journal Specifications
- PublisherELSEVIER IRELAND LTD
- LanguageEnglish
- FrequencyMonthly
- LanguageEnglish
- FrequencyMonthly
- Publication Start Year1985
- Publisher URL
- Website URL
Months | % Papers published |
---|---|
0-3 | 57% |
4-6 | 34% |
7-9 | 8% |
>9 | 1% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Lung Cancer been publishing? ![Faqs](assets/images/arrow-down.svg)
The Lung Cancer has been publishing since 1985 till date.
How frequently is the Lung Cancer published? ![Faqs](assets/images/arrow-down.svg)
Lung Cancer is published Monthly.
What is the H-index. SNIP score, Citescore and SJR of Lung Cancer? ![Faqs](assets/images/arrow-down.svg)
Lung Cancer has a H-index score of 141, Citescore of 9.4, SNIP score of 1.44, & SJR of Q1
Who is the publisher of Lung Cancer? ![Faqs](assets/images/arrow-down.svg)
The publisher of Lung Cancer is ELSEVIER IRELAND LTD.
Where can I find a journal's aims and scope of Lung Cancer? ![Faqs](assets/images/arrow-down.svg)
For the Lung Cancer's Aims and Scope, please refer to the section above on the page.
How can I view the journal metrics of Lung Cancer on editage? ![Faqs](assets/images/arrow-down.svg)
For the Lung Cancer metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Lung Cancer? ![Faqs](assets/images/arrow-down.svg)
The eISSN number is 1872-8332 and pISSN number is 0169-5002 for Lung Cancer.
What is the focus of this journal? ![Faqs](assets/images/arrow-down.svg)
The journal covers a wide range of topics inlcuding Cancer, Lung cancer, Lymph node, Progression-free survival, Computed tomography, Crizotinib, Immunotherapy, Exon, Immune checkpoint inhibitors, Epidermal growth factor receptor, Chemoradiotherapy, Overall survival, Lung, Adenocarcinoma, Toxicity, Artificial intelligence, Cohort study, Central nervous system, Met amplification, Mesothelioma.
Why is it important to find the right journal for my research? ![Faqs](assets/images/arrow-down.svg)
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? ![Faqs](assets/images/arrow-down.svg)
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? ![Faqs](assets/images/arrow-down.svg)
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.